Bavarian Nordic to Host Full Year 2011 Conference Call

Bavarian Nordic to Host Full Year 2011 Conference Call

ID: 121117

(Thomson Reuters ONE) -


KVISTGAARD, Denmark - March 2, 2012 - Bavarian Nordic A/S (OMX:  BAVA) announces
its 2011 full year results on Thursday, March 8.

The company will host a conference call at 3:30 pm CET (9:30 am EST) on the same
day. Anders Hedegaard, President and CEO, will give a short presentation
followed by a Q&A session. Additional participants from Bavarian Nordic are
Reiner Laus, Executive Vice President and Division President Cancer Vaccines,
Paul Chaplin, Executive Vice President and Division President Infectious
Diseases, Ole Larsen, CFO and Rolf Sass Sørensen, Vice President Investor
Relations.

Dial-in numbers for the conference call are:  UK: +44 (0)207 1620 177, US:
+1 334 323 6203, Denmark: +45 3271 4611. For additional details please visit
http://www.bavarian-nordic.com/ar2011 where also the accompanying presentation
will be available in advance of the conference call.

A recording of the conference call will be available from the company's website
during the same day.

Contact

Rolf Sass Sørensen, Vice President Investor Relations & Communications

E-mail: investor(at)bavarian-nordic.com

Phone: +45 33 26 83 83

About Bavarian Nordic

Bavarian Nordic is a vaccine-focused biotechnology company developing and
producing novel vaccines for the treatment and prevention of life-threatening
diseases with a large unmet medical need. The company's pipeline targets cancer
and infectious diseases, and includes ten development programs. In oncology, the
company's lead program is PROSTVAC®, a therapeutic vaccine candidate for
advanced prostate cancer that is the subject of an ongoing pivotal Phase 3 trial
and is being developed under a collaboration agreement with the National Cancer
Institute. In clinical Phase 1 and Phase 2 trials, PROSTVAC® has been tested in




nearly 600 patients. In infectious diseases, the company's lead program is
IMVAMUNE®, a third-generation smallpox vaccine candidate that is being developed
and supplied for emergency use to the U.S. Strategic National Stockpile under a
contract with the U.S. Government. For more information, visit www.bavarian-
nordic.com.







This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Bavarian Nordic A/S via Thomson Reuters ONE

[HUG#1590979]


Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Grontmij wins framework agreement with energy company National Grid Annexin A5 at low doses prevents atherosclerosis -  Study published in Atherosclerosis
Bereitgestellt von Benutzer: hugin
Datum: 02.03.2012 - 13:52 Uhr
Sprache: Deutsch
News-ID 121117
Anzahl Zeichen: 3009

contact information:
Town:

Kvistgård



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 142 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Bavarian Nordic to Host Full Year 2011 Conference Call"
steht unter der journalistisch-redaktionellen Verantwortung von

Bavarian Nordic A/S (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Bavarian Nordic A/S



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z